Three-dimensional (3D) Printed Hemodialysis Vascular Model
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT05096416
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hemodialysis Access Failure
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- The three-dimensional (3D) printed hemodialysis vascular model — DEVICEThe three-dimensional (3D) printed hemodialysis vascular model will be used as a guide map to cannulate the patients for hemodialysis and to minimize the risk of vascular access complications
Study Details
Infiltration of a surgically-placed hemodialysis vascular access (HVA) is recognized as a major contributor to the high hospital re-admission rate in dialysis-dependent patients. Three dimensional modeling has been demonstrated as a critical tool for procedurists in preparation for surgical interventions but no such modeling is yet available for dialysis specialists to avoid the common complication of HVA infiltration. Contrast enhanced magnetic resonance angiography (MRA) can be used to generate a three dimensional image data that could render a three dimensional resin-based model of a vascular access.
Key Dates
- Start date
- Jan 1, 2023
- Status verified
- Jul 2022
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Control armPatients in this arm will have standard of care where they will be annulated by the palpation method by the dialysis technician and nurse.
- Experimental: Intervention armPatients in this arm will have a three-dimensional (3D) printed vascular access model to assist the dialysis technician and nurse in cannulation.
Primary Outcome Measure
Quantify the number of dialysis treatments completed [ Time Frame: 12 month ]
Central Contacts
- Andrew Siedlecki, MD+13148092879
- Aliza Anwar Memon, MBBS+13479824073
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | - |
Find similar trials in Boston, MA
Related Studies
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas StudyRecruiting · VenoStent · Bullhead City, Arizona
- PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on HemodialysisRecruiting · Merit Medical Systems, Inc. · Washington D.C., District of Columbia